Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
What’s Behind the Strong Growth of the Orlistat Market Size in the Last 5 Years?
In recent times, the orlistat market has seen robust growth. The market is projected to increase from a value of $3.03 billion in 2024 to reach approximately $3.2 billion in 2025, reflecting a compound annual growth rate of 5.7%. This upward trend in the historical period can be attributed to factors such as rising public consciousness about health risks associated with obesity, the approval of orlistat as a prescribed medication by regulatory bodies, accessibility of orlistat at a lower dosage over-the-counter, endorsements from physicians, and escalating healthcare expenses linked to obesity.
Expectations are high for significant expansion of the orlistat market in the years to come. With a compound annual growth rate (CAGR) of 6.1%, it’s projected to reach a valuation of $4.07 billion by 2029. Factors contributing to this projected growth include an escalation in healthcare spending on obesity treatments, stagnant lifestyles coupled with poor dietary choices, government-backed weight loss initiatives, an older population, and the transition from prescription to over-the-counter medication. Throughout this projection period, prominent trends will encompass AI-powered dietary programs, telemedicine services, advanced devices for medication reminders and adherence tracking, virtual reality fitness sessions, and digital therapeutic solutions.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What Are the Key Drivers Fueling Growth in the Orlistat Market?
The orlistat market is projected to expand due to escalating obesity rates. Obesity, defined as a health disorder resulting from excessive accumulation of body fat affecting health adversely, is typically recognized by a body mass index (BMI) of 30 or above. The causes contributing to the increase in obesity include unhealthy eating habits, insufficient physical activity, and sedentary lifestyle practices.
Orlistat is commonly used for managing obesity as it blocks the absorption of dietary fats, which helps in reducing and maintaining weight loss. This drug is typically recommended to be taken in conjunction with a low-calorie diet and regular physical exercise to enhance the results. In March 2022, data from the World Health Organization (WHO), a synonym for an intergovernmental organization based in Switzerland, showed that over 1 billion people worldwide, consisting of 650 million adults, 340 million teenagers, and 39 million children are suffering from obesity. This number is expected to keep rising, with projections indicating that approximately 167 million people, inclusive of adults and children, will face health decline due to overweight or obesity by 2025. Hence, the escalating rates of obesity underpin the growth of the orlistat market.
Which Key Segments Are Driving Growth in the Orlistat Market?
The orlistatmarket covered in this report is segmented –
1) By Type: 120 Milligram (Mg); 60 Milligram(Mg)
2) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
3) By Application: Weight-Reducing Aid; Other Applications
Subsegments:
1) By 120 Milligram (Mg): Prescription-Based 120 Mg Orlistat; Over-The-Counter (OTC) 120 Mg Orlistat
2) By 60 Milligram (Mg): Over-The-Counter (OTC) 60 Mg Orlistat; Prescription-Based 60 Mg Orlistat
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
Which Emerging Trends Will Impact the Orlistat Market in the Forecast Period?
Leading businesses in the orlistat industry are working on creating cutting-edge products like weight loss medications, aimed at improving personal hygiene and comfort through superior technology and design. Weight loss medications are developed to assist people in losing body weight by suppressing hunger, boosting metabolism, or preventing fat assimilation. For example, in November 2023, Eli Lilly and Company, a pharmaceutical organization based in the US, gained approval from the US Food and Drug Administration (FDA) for Zepbound (tirzepatide) injection, a novel weight loss drug. It’s the only approved treatment that activates both GIP and GLP-1 incretin hormone receptors, dealing with a primary cause of excessive weight. Zepbound is recommended for use alongside a calorie-reduced diet and increased physical exercise for sustained weight control in adults who are obese (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) and have at least one weight-related health issue.
Which Geographies Are Leading the Expansion of the Orlistat Market?
North America was the largest region in the orlistat market in 2024. The regions covered in the orlistat market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Who Are the Top Companies Dominating the Orlistat Market in 2025?
Major companies operating in the orlistat market are Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Roche Holding AG, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Intas Pharmaceuticals Ltd., Lupin Pharmaceuticals Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Zydus Life, Emcure Pharmaceuticals Ltd., Lannett Company Inc., Strides Pharma Science Ltd., Indoco Remedies Ltd., Wockhardt Ltd., Jubilant Life Sciences Ltd.
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=18422
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
